Polypharmacy rising among seniors with heart failureQuebecers aged 65 and over with heart failure are taking more and more different pharmacological treatments, according to a new study Canadian antiplatelet guidelines update: changes include no ASA for routine primary prevention of cardiac diseaseOther changes include recommendations for de-escalation of dual antiplatelet therapy in select patients and dual antiplatelet therapy post-CABG. Do supplements, psyllium or probiotics work to lower cholesterol? There’s some evidence that taking particular supplements, while also eating a healthy diet, can make a difference CPAP use may reduce secondary CVD events As long as people use the devices at least four hours per day. An app to save precious time during a heart attack? Developer describes technology, currently being deployed at Montreal hospitals, as the “Uber Eats of critical care.” Myocardial infarction: Aspirin reduces the risk of recurrence and death Researchers explore risks associated with stopping Aspirin long-term. Simplified Canadian lipid guidelines for primary care providers Updated evidence-based guidelines provide a simplified approach to lipid management for the prevention and management of cardiovascular disease. Cardiovascular disease in women Complication during childbirth: How to advise women who are at risk of recurrence Study shows women who suffered cardiac complications during their first delivery were most at risk for experiencing a second delivery with serious consequences. Should patients with psoriasis be screened for CVD? Study shows impaired microcirculation in the heart, even in patients with no CVD symptoms. First Previous 6 7 8 9 10 Next Last